Sarah Elizabeth

aspiring breast oncologist @hopkins_hemeonc, @georgetown IM, former @NIH research fellow, distance runner, @anthropologie enthusiast

[Paolo Tarantino @PTarantinoMD]

One week to #ESMO25. An unprecedented ESMO conference. Seven positive press releases, anticipating the expansion of T-DXd to the curative setting, two Trop2 ADCs reaching first-line mTNBC, 2 novel ET-based combos, adjuvant CDK4/6i improving OS. See you in Berlin! #ESMOAmbassadors

[Sarah Elizabeth @semuds]

@Joshua_Reuss @kamarroneMD @HopkinsThoracic the fun section !! 🎉

[Joshua Reuss @Joshua_Reuss]

Honored to present our data on neoadjuvant nivolumab and nivolumab/ipilimumab in potentially resectable diffuse pleural mesothelioma (DPM) at #WCLC25. @IASLC

We evaluated perioperative nivo and nivo/ipi in epithelioid or biphasic DPM deemed resectable by multi-D assessment. 1/7

[Sarah Elizabeth @semuds]

@kamarroneMD @DenaRhinehart @Hopkins_HemOnc @hopkinskimmel proud of ya, lady !! 🥰

[Kristen A. Marrone, MD @kamarroneMD]

Beyond proud of this incredible, dedicated, brilliant physician/chief fellow/colleague 🤩

Way to go @DenaRhinehart

@Hopkins_HemOnc @hopkinskimmel

[Johns Hopkins Hematology and Oncology Fellowship @Hopkins_HemOnc]

A cherished tradition continues! Each year, our new oncology fellows assemble for a photo in front of the iconic Hopkins Dome. Welcome to the new 2025 fellows! @KiarashSalafian @kamarroneMD @NimgaonkarVivek @v_altiery @MarkYarchoan

[Johns Hopkins Hematology and Oncology Fellowship @Hopkins_HemOnc]

As we enter spring, your arrival feels even closer! Excited to welcome you soon @PaolaGhanem @jonnypan17 @v_altiery @MetBalev @NimgaonkarVivek @KiarashSalafian

[SABCS @SABCSSanAntonio]

#SABCS24 Preview: A Thursday afternoon panel discussion will highlight genetic variants associated with inherited breast cancer risk. Learn more in SABCS Meeting News:
https://t.co/ktiArStTZ4

[Ankit Agrawal @AnkitAgrawalMD]

Excited to share our work on immune check point inhibitors related pericardial diseases published in Cardio-Oncology under the mentorship of Dr. @AllanLKleinMD1
@BioMedCentral #CardioOncology @ICOSociety @DocMajid @mdyesilyaprak @Syed_Alveena

https://t.co/a2QbIsKMKE

[Pericarditis Alliance @PericarditisA]

Stay informed with the Pericarditis Alliance! Check out this new study from Cardio-Oncology, Immune checkpoint inhibitors and pericardial disease: a systematic review. https://t.co/gH8BYuhexX

[JAMA Oncology @JAMAOnc]

This study found that women with breast cancer who used vaginal estrogen therapy (vaginal creams or vaginal tablets), compared with no hormone replacement therapy use, did not appear to have an increased risk of early breast cancer-specific mortality. https://t.co/gkIRPQrcMC

[David Steensma, MD @DavidSteensma]

Thank you to ⁦@ASH_hematology⁩ for inviting me to create the 13th (I think? Maybe 14th) edition of the annual ASH News Daily Hematology Crossword puzzle! #ASH23 (People have liked these enough that I got to do 3 for other societies’ annual meetings this year)

[Tatiana Prowell, MD @tmprowell]

Updated #KATHERINE results #SABCS23
Final IDFS at 8.4 yr median f/u: Risk of recurrence reduced by ~1/2 w/ switch to post-neoadjuvant T-DM1 for those w/ HER2+ EBC & residual disease (abs risk reduction 13.7%) & risk of death reduced by ~1/3 (abs improvement in OS 4.7%). #bcsm /1

[Ilana Schlam @IlanaSchlam]

2023 was an outstanding year for breast cancer research
As we start wrapping up #SABCS23, we need to think about how to incorporate what we learned in the clinic and future research.
Looking forward to what is yet to come to improve outcomes for our patients!
@OncoAlert #BCSM

[Julia Maués @itsnot_pink]

While the OS difference isn’t huge, it’s so important to highlight that side effects of TDM1 are a WHOLE ‘NOTHER LEVEL compared to the newer ADCs! We have definitely gone in the wrong direction when it comes to QoL!

#SABCS23 @SABCSSanAntonio @OncoAlert

[Erika Hamilton, MD, FASCO @ErikaHamilton9]

Really interesting and all the way your statistical power is allocated in a trial.

#SABCS23

[Legorreta Cancer Center at Brown University @BrownUCancer]

We strongly support Dr. Stephanie Graff & encourage colleagues in the field of Oncology to support her for @ASCO’s Nominating Committee. #LegorretaCancerCenter @BrownUCancer @ASCO Vote for @ASCO’s elected leadership team at https://t.co/bCwq95IWNG for a bright future in Oncology.

[UofL Medicine @UofLMedicine]

Dr. Brian Dong of @UofLHealth, @UofLBCC and the @uoflmedschool will present "Update in #breastcancer Genetics and High-Risk Breast Disease" at @uofl Medicine Grand Rounds #PowerofU #cancer #oncology

🕗📅 - 8 a.m. Thursday, Sept. 22
👀💻 - https://t.co/70nLpEXbtx

[Paolo Tarantino @PTarantinoMD]

Reading good review articles can shape ideas, help connecting the dots and understanding what’s coming ahead in science.

Here’s 10 review articles that helped me shape my views on breast oncology and drug development:

[Paolo Tarantino @PTarantinoMD]

The largest study to date (N=1.13M❗️) on the prognostic value of HER2-low expression is out on @JAMAOnc. With an HR 0.98 & overlapping OS curves, HER2-low confirms not to be a relevant predictor of prognosis. Congrats to the authors for this huge analysis!
https://t.co/nW5ZvIxSX0